Cost-effectiveness of rivaroxaban compared with warfarin for stroke prevention in atrial fibrillation
Kapur, A. K., Chatzitheofilou, I. & Schang, L. K.
(2012).
Cost-effectiveness of rivaroxaban compared with warfarin for stroke prevention in atrial fibrillation.
Value in Health,
15(4), A122.
https://doi.org/10.1016/j.jval.2012.03.660
| Item Type | Article |
|---|---|
| Copyright holders | © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) |
| Departments | LSE |
| DOI | 10.1016/j.jval.2012.03.660 |
| Date Deposited | 24 Sep 2012 |
| URI | https://researchonline.lse.ac.uk/id/eprint/46322 |
Explore Further
- https://www.scopus.com/pages/publications/84865456696 (Scopus publication)
- http://www.valueinhealthjournal.com/ (Official URL)